Fig. 5.
Fig. 5. Microvessels in sections of decalcified human bones of thalidomide-responsive myelomatous SCID-hu B+L hosts. / (A-B) Patient 9; (C-D) patient 10. Microvessels in sections from CMC-treated (A,C) and thalidomide-treated (B,D) SCID-hu hosts were visualized using immunohistochemical staining for human CD34 expression.

Microvessels in sections of decalcified human bones of thalidomide-responsive myelomatous SCID-hu B+L hosts.

(A-B) Patient 9; (C-D) patient 10. Microvessels in sections from CMC-treated (A,C) and thalidomide-treated (B,D) SCID-hu hosts were visualized using immunohistochemical staining for human CD34 expression.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal